Anne Quinquenel

13PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumoursGenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 15, 2026
Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.

Arthur Coste, Nanthara Sritharan, Anne Lok

|Jan 07, 2026
POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.

Saurabh Zanwar, Jithma Abeykoon, Shirley D'Sa

|Jul 30, 2025
Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS).

Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy

|Sep 07, 2021
Myeloid malignancies with translocation t(4;12)(q11-13;p13): molecular landscape, clonal hierarchy and clinical outcomes.

Vincent Parinet, Elise Chapiro, Audrey Bidet

|Jun 21, 2021
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).

Grégory Lazarian, Michaël Munger, Anne Quinquenel

|May 17, 2021
Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: A study of the French Innovative Leukemia Organization.

Charline Moulin, Francis Guillemin, Thomas Remen

Pageof 3

Frequent Collaborators

6 joint publications

Damien Roos-Weil

4 joint publications

Eric Durot

3 joint publications

Loïc Ysebaert

2 joint publications

Alain Delmer